Preloader Close
Unimrkt Healthcare Powered By Unimrkt Research
  • Industry: Business Research
  • Study Type: Zevicefta and Disease Profile (cIAI, cUTI & HAP|VAP) Study
  • Client: A Leading Pharmaceutical Company

Background & Key Objectives

  • Landscape report on Hospital & Ventilator Acquired Pneumonia (HAP|VAP), Complicated Urinary track infection (cUTI)|Pyelonephritis and Complicated Intra-Abdominal Infection (cIAI).
  • Detailed profile on Zavicefta (Ceftazidime-avibactam) for USA and EU.

Methodology & Approach

  • Performed an exhaustive desk research on the Zavicefta and Hospital & Ventilator Acquired Pneumonia (HAP|VAP), Complicated Urinary track infection (cUTI)|Pyelonephritis and Complicated Intra-Abdominal Infection (cIAI).
  • Referred multiple sources like USA FDA, EMEA, Orange book, clincialtrials.gov, CDC, and others along with open search
  • Zevicefta profile
    1. Overview, chemical structure, dosage and administration, clinical updates, sales, investments, regulatory updates, etc. .
  • The study aimed to gather deep information on the diseases like cIAI, cUTI & HAP, where our team presented an overview of these diseases, its risk factors, symptoms, diagnosis, treatment strategy & algorithm, economic burden, etc.
    1. Pipeline analysis on investigational agents in Phase 2/3
    2. Comparative assessment of existing brands

Our Solution

  • The study helped the end client to make tweaks in the sales and marketing of their existing products.
  • Also, this desk research study aided the client to develop and launch a new and more effective drug for these diseases.
  • Final report in PPT format (135 slides)